Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

GHTC Capitol Hill Reception Helps Launch G-FINDER Report On Neglected Disease R&D Funding

Global Health Technologies Coalition’s “Breakthroughs”: Celebrating U.S. leadership in global health R&D on Capitol Hill GHTC Communications Officer Marissa Chmiola writes, “On Wednesday evening, GHTC was joined on Capitol Hill by congressional champions — Congressman Adam Smith (WA-9) and Congresswoman Betty McCollum (MN-4) — and global health community members for…

Newsweek Feature Examines Challenges Of Diagnosing, Treating, Preventing TB

Newsweek: Invisible Killer: The World’s Most Underestimated Disease “…[Tuberculosis is] an unsexy disease that affects those living in the shadows of society. Researchers, doctors, professors, and health care workers all agree that tuberculosis does not get the attention or investment from international donors that such a deadly killer — the…

Blog Examines Respiratory Syncytial Virus Vaccine R&D

Bill & Melinda Gates Foundation’s “Impatient Optimists”: New Hope for Respiratory Syncytial Virus (RSV) Prevention Niteen Wairagkar, senior program officer with the global health program’s pneumonia team at the Bill & Melinda Gates Foundation, discusses the need for and research into vaccines for respiratory syncytial virus (RSV), a leading cause…

GlaxoSmithKline’s ViiV Healthcare To Purchase Experimental HIV Medicines From Bristol-Myers Squibb For Up To $1.46B

Bloomberg Business: Glaxo to Pay Bristol-Myers Up to $1.46 Billion for HIV Drugs “GlaxoSmithKline Plc agreed to buy Bristol-Myers Squibb Co.’s portfolio of experimental HIV treatments for as much as $1.46 billion in two transactions, bolstering one of the U.K. drugmaker’s fastest-growing businesses…” (Serafino/Kitamura, 12/18). Financial Times: GSK spends up…

USAID Shares 15 Highlights From Agency’s 2015 Global Health Efforts

USAID: A Year in Review: 2015 USAID shares 15 “key global health events, milestones, and highlights from the past 12 months [describing the agency’s efforts] to end preventable child and maternal deaths, create an AIDS-free generation, and protect communities from infectious diseases, all in support of a world free of extreme poverty…”…

‘Science Speaks’ Examines 2 Articles On Public Health, Economic Impacts Of HIV Efforts

Center for Global Health Policy’s “Science Speaks”: Modeling does the math to add up impacts of HIV answers in the works Antigone Barton, senior writer and editor of “Science Speaks,” examines two recently released papers that discuss the public health and economic impacts of HIV efforts. The first paper “examines…

China Develops 2 Vaccines For More Severe Form Of Hand, Foot, Mouth Disease

Bill & Melinda Gates Foundations’ “Impatient Optimists”: Severe Hand, Foot, and Mouth Disease (HFMD) is now vaccine-preventable (at least in China)! Melvin Sanicas, global health fellow and program officer at the Bill & Melinda Gates Foundation, discusses China’s development of two vaccines for hand, foot, and mouth disease (HFMD), which…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.